Amdocs (NASDAQ:DOX) Stock Rating Lowered by Zacks Research

Key Points

• Zacks Research downgraded Amdocs to “strong sell” from “hold,” adding to mixed analyst views; MarketBeat’s consensus rating remains “Hold,” with a $78.33 price target.
• Amdocs shares opened at $41.46, near their 12-month low of $39.96. News cited a projected 7%–11% fiscal 2027 revenue decline amid a dispute with T-Mobile and multiple law-firm investigations.
• The company’s latest quarterly results met expectations, with EPS of $1.98 and revenue of $1.19 billion; revenue rose 3.8% year over year.

Amdocs (NASDAQ:DOX - Get Free Report) was downgraded by Zacks Research from a "hold" rating to a "strong sell" rating in a research report issued to clients and investors on Monday, Zacks reports.

DOX has been the topic of a number of other research reports. Wall Street Zen downgraded shares of Amdocs from a "buy" rating to a "hold" rating in a report on Saturday. Oppenheimer lowered shares of Amdocs from an "outperform" rating to a "market perform" rating in a research note on Wednesday, November 4th. Weiss Ratings raised shares of Amdocs from a "sell (d+)" rating to a "hold (c-)" rating in a report on Friday, October 23rd. Finally, Stifel Nicolaus lowered their price objective on shares of Amdocs from $71.00 to $46.00 and set a "buy" rating on the stock in a research report on Wednesday, November 4th. Three analysts have rated the stock with a Buy rating, four have issued a Hold rating and two have issued a Sell rating to the stock. According to MarketBeat, the stock has an average rating of "Hold" and a consensus target price of $78.33.

Amdocs Stock Performance

Shares of DOX opened at $41.46 on Monday. The company has a market cap of $4.48 billion, a price-to-earnings ratio of 6.30, a P/E/G ratio of 1.36 and a beta of 0.42. The business's fifty day simple moving average is $58.64 and its two-hundred day simple moving average is $61.57. Amdocs has a 12 month low of $39.96 and a 12 month high of $85.63. The company has a current ratio of 0.94, a quick ratio of 0.94 and a debt-to-equity ratio of 0.23.

Amdocs (NASDAQ:DOX - Get Free Report) last posted its quarterly earnings results on Tuesday, November 3rd. The technology company reported $1.98 earnings per share for the quarter, hitting the consensus estimate of $1.98. The firm had revenue of $1.19 billion during the quarter, compared to analysts' expectations of $1.19 billion. Amdocs had a return on equity of 20.81% and a net margin of 10.59%. The company's revenue was up 3.8% on a year-over-year basis. During the same quarter in the previous year, the business earned $1.83 earnings per share. Research analysts anticipate that Amdocs will post 5.82 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Institutional investors have recently added to or reduced their stakes in the business. Pzena Investment Management LLC grew its position in shares of Amdocs by 3.4% during the 3rd quarter. Pzena Investment Management LLC now owns 14,454,911 shares of the technology company's stock valued at $826,532,000 after acquiring an additional 469,581 shares during the period. Dimensional Fund Advisors LP raised its holdings in Amdocs by 19.7% in the 1st quarter. Dimensional Fund Advisors LP now owns 3,463,797 shares of the technology company's stock worth $226,045,000 after purchasing an additional 571,036 shares during the period. Bank of America Corp DE raised its holdings in Amdocs by 29.1% in the 1st quarter. Bank of America Corp DE now owns 1,262,263 shares of the technology company's stock worth $82,375,000 after purchasing an additional 284,435 shares during the period. First Trust Advisors LP raised its holdings in Amdocs by 13.9% in the 1st quarter. First Trust Advisors LP now owns 1,077,258 shares of the technology company's stock worth $70,302,000 after purchasing an additional 131,197 shares during the period. Finally, Russell Investments Group Ltd. lifted its position in Amdocs by 11.2% during the third quarter. Russell Investments Group Ltd. now owns 1,112,976 shares of the technology company's stock valued at $63,703,000 after purchasing an additional 111,800 shares in the last quarter. 92.02% of the stock is currently owned by institutional investors.

Trending Headlines about Amdocs

Here are the key news stories impacting Amdocs this week:

• Positive Sentiment: Amdocs said it was named a Leader in Gartner’s 2026 Magic Quadrant for CSP AI-enabled marketing and sales solutions, a potentially supportive signal for its product positioning. Article: Amdocs Named a Leader in the 2026 Gartner Magic Quadrant
• Neutral Sentiment: A short-interest report says short interest totaled zero shares as of November 10, despite describing a significant increase. The figures appear inconsistent and provide no clear indication of short-selling pressure.
• Negative Sentiment: Multiple law firms announced investigations into potential securities claims related to Amdocs’ disclosures and T-Mobile agreement issues. The reports cite the roughly 30% stock decline on November 4 after the company projected a 7%–11% revenue decline in fiscal 2027 amid an escalating T-Mobile dispute. The investigations may prolong uncertainty for investors. Article: Pomerantz investigation Article: Block & Leviton investigation Article: BFA Law investigation
• Negative Sentiment: Zacks added DOX to its Rank #5 (Strong Sell) list, reinforcing a bearish analyst signal. Article: New Strong Sell Stocks for November 10th

Amdocs Company Profile

Amdocs provides software and services to communications and media companies. Its offerings include business and operational support systems for billing, customer management, service delivery and network operations, as well as cloud and digital solutions that help clients modernize their businesses and improve customer experiences. Founded in 1982, Amdocs serves communications and media providers in markets around the world. The company is headquartered in the St. Louis, Missouri, area and is led by President and Chief Executive Officer Shuky Sheffer.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.